60376-73-0
60376-73-0 structure
- Name: methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate
- Chemical Name: methyl 3-(dimethylaminomethylideneamino)sulfonyl-5-nitro-4-phenoxybenzoate
- CAS Number: 60376-73-0
- Molecular Formula: C17H17N3O7S
- Molecular Weight: 407.39800
- Create Date: 2016-10-20 19:42:51
- Modify Date: 2024-01-09 17:54:40
| Name | methyl 3-(dimethylaminomethylideneamino)sulfonyl-5-nitro-4-phenoxybenzoate |
|---|---|
| Synonyms |
methyl 3-({[(dimethylamino)methylene]amino}sulfonyl)-5-nitro-4-phenoxybenzoate
3-nitro-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester 3-(dimethylaminomethylenesulfamoyl)-5-nitro-4-phenoxybenzoic acid methyl ester Methyl 3-((((dimethylamino)methylene)amino)sulphonyl)-5-nitro-4-phenoxybenzoate |
| Density | 1.36g/cm3 |
|---|---|
| Boiling Point | 544.9ºC at 760 mmHg |
| Molecular Formula | C17H17N3O7S |
| Molecular Weight | 407.39800 |
| Flash Point | 283.3ºC |
| Exact Mass | 407.07900 |
| PSA | 139.47000 |
| LogP | 4.05630 |
| Index of Refraction | 1.595 |
| HS Code | 2935009090 |
|---|
|
~%
60376-73-0 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2 |
|
~%
60376-73-0 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
|
~%
60376-73-0 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
|
~%
60376-73-0 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 Title/Abstract Full Text Show Details NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen, P.; COLLINS, Stephen, D.; KINCAID, John; DODSON, Gary, Steven Patent: WO2013/59648 A1, 2013 ; |
| HS Code | 2935009090 |
|---|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |